These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 18656197)

  • 41. Novel aspects of endothelium-dependent regulation of vascular tone.
    Villar IC; Francis S; Webb A; Hobbs AJ; Ahluwalia A
    Kidney Int; 2006 Sep; 70(5):840-53. PubMed ID: 16837917
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Novel mechanism of vasodilatation].
    Ohashi J; Shimokawa H
    Nihon Rinsho; 2010 Apr; 68(4):631-5. PubMed ID: 20387553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endothelium-derived hyperpolarizing factor as an in vivo back-up mechanism in the cutaneous microcirculation in old mice.
    Gaubert ML; Sigaudo-Roussel D; Tartas M; Berrut G; Saumet JL; Fromy B
    J Physiol; 2007 Dec; 585(Pt 2):617-26. PubMed ID: 17932144
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of endothelium-derived hyperpolarizing factor and nitric oxide on endothelial function in femoral resistance arteries of spontaneously hypertensive rats.
    Mori Y; Ohyanagi M; Koida S; Ueda A; Ishiko K; Iwasaki T
    Hypertens Res; 2006 Mar; 29(3):187-95. PubMed ID: 16755154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo.
    Scotland RS; Madhani M; Chauhan S; Moncada S; Andresen J; Nilsson H; Hobbs AJ; Ahluwalia A
    Circulation; 2005 Feb; 111(6):796-803. PubMed ID: 15699263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelium-derived hyperpolarizing factor: a key mediator of the vasodilator action of bradykinin.
    Mombouli JV; Bissiriou I; Agboton V; Vanhoutte PM
    Immunopharmacology; 1996 Jun; 33(1-3):46-50. PubMed ID: 8856114
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans.
    Matoba T; Shimokawa H
    J Pharmacol Sci; 2003 May; 92(1):1-6. PubMed ID: 12832848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The endothelium in health and in cardiovascular disease.
    Garćia-Palmieri MR
    P R Health Sci J; 1997 Jun; 16(2):136-41. PubMed ID: 9285990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice.
    Takaki A; Morikawa K; Murayama Y; Yamagishi H; Hosoya M; Ohashi J; Shimokawa H
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):510-7. PubMed ID: 19034034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hydrogen peroxide as an endothelium-derived hyperpolarizing factor.
    Shimokawa H; Matoba T
    Pharmacol Res; 2004 Jun; 49(6):543-9. PubMed ID: 15026032
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The endothelium-derived hyperpolarizing factor: insights from genetic animal models.
    Köhler R; Hoyer J
    Kidney Int; 2007 Jul; 72(2):145-50. PubMed ID: 17457372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities-from bench to bedside.
    Shimokawa H
    Eur Heart J; 2014 Dec; 35(45):3180-93. PubMed ID: 25354517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identifying endothelium-derived hyperpolarizing factor: recent approaches to assay the role of epoxyeicosatrienoic acids.
    Medhora M; Narayanan J; Harder D; Maier KG
    Jpn J Pharmacol; 2001 Aug; 86(4):369-75. PubMed ID: 11569609
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EDHF and gap junctions: important regulators of vascular tone within the microcirculation.
    de Wit C; Wölfle SE
    Curr Pharm Biotechnol; 2007 Feb; 8(1):11-25. PubMed ID: 17311549
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelium-dependent hyperpolarizations: the history.
    Vanhoutte PM
    Pharmacol Res; 2004 Jun; 49(6):503-8. PubMed ID: 15026027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New molecular mechanisms for cardiovascular disease: contribution of endothelium-derived hyperpolarizing factor in the regulation of vasoconstriction in peripheral resistance arteries.
    Jin X; Satoh-Otonashi Y; Zamami Y; Takatori S; Hashikawa-Hobara N; Kitamura Y; Kawasaki H
    J Pharmacol Sci; 2011; 116(4):332-6. PubMed ID: 21757845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products.
    Matz RL; Schott C; Stoclet JC; Andriantsitohaina R
    Physiol Res; 2000; 49(1):11-8. PubMed ID: 10805400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endothelial dysfunction: from physiology to therapy.
    Mombouli JV; Vanhoutte PM
    J Mol Cell Cardiol; 1999 Jan; 31(1):61-74. PubMed ID: 10072716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The endothelium in health and disease: A discussion of the contribution of non-nitric oxide endothelium-derived vasoactive mediators to vascular homeostasis in normal vessels and in type II diabetes.
    Triggle CR; Ding H; Anderson TJ; Pannirselvam M
    Mol Cell Biochem; 2004 Aug; 263(1):21-7. PubMed ID: 27520662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endothelium-derived hyperpolarizing factor (EDHF).
    Suzuki H; Chen G; Yamamoto Y
    Jpn Circ J; 1992 Feb; 56(2):170-4. PubMed ID: 1548837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.